STAT18h
Eli Lilly’s Alzheimer’s drug gets thumbs-down from European regulators
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.
Business Wire1mon
European Medicines Agency Validates Gilead’s Marketing Authorization Application and EU-Medicines for All Application for Twice-Yearly Lenacapavir for HIV Prevention
--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA ... “Achieving another key regulatory milestone so soon after the U.S. FDA ...
Hosted on MSN17d
Commission to push 'buy European' in new critical medicines act
The EU executive included a new 'Buy Europe' mechanism with its long-awaited proposal for a Critical Medicines Act, unveiled on Tuesday, a key piece of health ... medicinal products drafted by the ...
5 takeaways on the Critical Medicines Act
From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at ...
Reuters6mon
European Medicines Agency
European regulators to review GSK's asthma drug Nucala to treat COPD The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
The Jerusalem Post Blogs27d
NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial
PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency ... Monitoring a person includes tracking changes in a person ...